Browsing: Head and Neck

Top Line:Prescription de-escalation to 60 Gy remains an intriguing, albeit investigational, strategy for early-stage p16+ oSCC.The Study:A post hoc comparison…

A single-armphase II trial treated 20 patients with unresectable and/or metastatic head and neck squamous cell carcinoma with pembrolizumab plus…

The Headline: Can imaging of tumor hypoxia guide radiation dose de-escalation for HPV+ oropharyngeal cancer?The Study: We’ve previously seen results…

An interesting critique of the widely-circulated phase 3 trial reporting an unexpected improvement in overall survival with the use of…

Top Line: Simul has sparked critical thinking about the realized clinical benefit of simultaneous integrated boosts (SIB) for head and…

Top Line: What are the long term outcomes following de-intensified adjuvant radiation following transoral surgery for oropharyngeal cancer? The Study:…

A MSKCC retrospective propensity-matched dosimetric analysis of 575 patients with HPV+ oropharyngeal cancer compared standard elective dosing (50–60 Gy) with…

For decades, the Quad Shot regimen has provided a common-sense strategy to palliate symptomatic tumors in an extremely low-burden yet…

This retrospective analysis of 382 such cases at UPMC concludes prior diagnostic tonsillectomy before trans-oral robotic surgery for HPV+ tonsillar…

This prospective study performed comprehensive taste testing of 50 patients before, during, and after head and neck radiation. Overall taste…